Our findings were consistent with those of the previous study, in that high mRNA expression levels of SLC39A6 and SLC39A14 indicated favorable OS, but upregulated SLC39A2-5, SLC39A7, and SLC39A12-13 were associated with poor OS in the patients with breast carcinoma (Liu et al., 2020). The gene discussed is SLC39A6; the disease is breast carcinoma.